IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis
- PMID: 26857496
- PMCID: PMC4849275
- DOI: 10.1016/j.jneuroim.2015.12.009
IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis
Abstract
IL-12Rβ2 is a common receptor subunit of heterodimeric receptors for IL-12 and IL-35, two cytokines that are implicated in immunopathogenesis of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. We evaluated the role of IL-12Rβ2 in relapsing-remitting EAE (RR-EAE). IL-12Rβ2-deficient SJL/J mice developed markedly more severe clinical EAE, and had greater mortality and more severe relapses compared with wild-type controls. IL-12Rβ2-deficient EAE mice also had more infiltrating mononuclear cells in the CNS, as well as higher T cell proliferative capacity and decreased IFN-γ production at the periphery. These findings demonstrate a protective role of IL-12Rβ2 in RR-EAE.
Keywords: Experimental autoimmune encephalomyelitis (EAE); IL-12; IL-12Rβ2; IL-35; Relapse.
Copyright © 2015. Published by Elsevier B.V.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures






Similar articles
-
Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.Int Immunopharmacol. 2009 Jan;9(1):134-43. doi: 10.1016/j.intimp.2008.10.015. Epub 2008 Nov 18. Int Immunopharmacol. 2009. PMID: 19022403
-
Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.J Neurol Sci. 2014 May 15;340(1-2):117-22. doi: 10.1016/j.jns.2014.02.039. Epub 2014 Mar 11. J Neurol Sci. 2014. PMID: 24655735
-
Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system.J Immunol. 2003 Feb 15;170(4):2153-60. doi: 10.4049/jimmunol.170.4.2153. J Immunol. 2003. PMID: 12574388
-
Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination.Crit Rev Immunol. 2004;24(2):111-28. doi: 10.1615/critrevimmunol.v24.i2.20. Crit Rev Immunol. 2004. PMID: 15581393 Review.
-
Experimental models of relapsing-remitting multiple sclerosis: current concepts and perspective.Curr Neurovasc Res. 2005 Oct;2(4):349-62. doi: 10.2174/156720205774322601. Curr Neurovasc Res. 2005. PMID: 16181126 Review.
Cited by
-
Cannabinoids' Role in Modulating Central and Peripheral Immunity in Neurodegenerative Diseases.Int J Mol Sci. 2024 Jun 10;25(12):6402. doi: 10.3390/ijms25126402. Int J Mol Sci. 2024. PMID: 38928109 Free PMC article. Review.
-
Oligodendrocyte-derived extracellular vesicles as antigen-specific therapy for autoimmune neuroinflammation in mice.Sci Transl Med. 2020 Nov 4;12(568):eaba0599. doi: 10.1126/scitranslmed.aba0599. Sci Transl Med. 2020. PMID: 33148622 Free PMC article.
-
Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells.Front Pharmacol. 2018 Oct 31;9:1237. doi: 10.3389/fphar.2018.01237. eCollection 2018. Front Pharmacol. 2018. PMID: 30429789 Free PMC article.
-
A bibliometric analysis of IL-35 research from 2009 to 2018.PeerJ. 2019 Oct 30;7:e7992. doi: 10.7717/peerj.7992. eCollection 2019. PeerJ. 2019. PMID: 31687283 Free PMC article.
-
IL-35 promotes CD4+Foxp3+ Tregs and inhibits atherosclerosis via maintaining CCR5-amplified Treg-suppressive mechanisms.JCI Insight. 2021 Oct 8;6(19):e152511. doi: 10.1172/jci.insight.152511. JCI Insight. 2021. PMID: 34622804 Free PMC article.
References
-
- Aube B, Levesque SA, Pare A, Chamma E, Kebir H, Gorina R, et al. Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases. Journal of immunology. 2014;193:2438–2454. - PubMed
-
- Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235–238. - PubMed
-
- Billiau A, Heremans H, Vandekerckhove F, Dijkmans R, Sobis H, Meulepas E, et al. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. Journal of immunology. 1988;140:1506–1510. - PubMed
-
- Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus. Journal of immunology. 2009;182:1689–1695. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases